Nobivac NXT HC RSS Authorised This medicine is authorised for use in the European Union feline calicivirosis and feline viral rhinotracheitis vaccine (live)MedicineVeterinaryAuthorised
Page contentsPage contents Overview Product details Authorisation details Assessment history News on Nobivac NXT HC Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Product details Name of medicine Nobivac NXT HC Active substance feline herpesvirus 1 (FHV), strain G2620A, livefeline calicivirus (FCV), strain F9, live International non-proprietary name (INN) or common name feline calicivirosis and feline viral rhinotracheitis vaccine (live) Pharmacotherapeutic groupImmunologicals for felidaeLive viral vaccinesfeline rhinotracheitis virus + feline calicivirus Authorisation details EMA product number EMEA/V/C/006702 Assessment history Initial marketing authorisation documents CVMP summary of positive opinion for Nobivac NXT HCAdopted Reference Number: EMA/CVMP/104787/2026 English (EN) (147.31 KB - PDF)First published: 22/05/2026 View News on Nobivac NXT HC Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 19-21 May 202622/05/2026 This page was last updated on 10/07/2026 Share this page